Abbott Laboratories reported its fourth-quarter earnings on Wednesday. Here's what you need to know.
PROFIT/LOSS: Abbott said it lost 50 cents a share in the fourth quarter mostly because of $1.46 billion in expenses related to tax reform, it said. The company made 74 cents a share not including that impact and others, beating estimates of analysts polled by Thomson Reuters of 73 cents.
Continue Reading Below
REVENUE: Comparable operational sales rose 7.7%. The company said established pharmaceuticals sales grew by 14%.
GUIDANCE: Abbott expects adjusted earnings for 2018 to be between $2.80 and $2.90 a share. For the first quarter of 2018, it expects adjusted earnings per share of between 57 and 59 cents.
STOCK MOVE: Shares rose 2.7% premarket Wednesday and is up 47% in the past year.
Write to Allison Prang at email@example.com
(END) Dow Jones Newswires
January 24, 2018 09:12 ET (14:12 GMT)